( A ) Plasma d 3 -TMAO concentrations in sequential venous blood draws after oral d 3 -l-carnitine challenge in vegans ( n = 7) and omnivores ( n = 8) at baseline, visit 1 (V1, 1 month), and visit 2 (V2, 23 months)
Diabetes Care 35:252258 Knudsen LB, Nielsen PF, Huusfeldt PO et al (2000) Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration
In one published case, an active, lean-adjacent man lost about one-third of his total weight as muscle on 2.5 mg and recovered it after adding resistance training and increasing protein. This is a cautionary case, not an incidence estimate
Trimethylamine N-oxide and outcomes in patients hospitalized with acute heart failure and preserved ejection fraction
If confirmed, they may help explain the therapeutic effects that psychedelics can have on anxiety, depression and addiction, researchers said
The study can inform policy changes that expand insurance coverage for GLP-1 drugs across a wider range of insurance plans, employment industries, income levels, sex, and other factors